Swiss National Bank Trims Holdings in The Clorox Company (NYSE:CLX)

Swiss National Bank decreased its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 5.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 349,300 shares of the company's stock after selling 19,300 shares during the quarter. Swiss National Bank owned approximately 0.28% of Clorox worth $56,730,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in CLX. State Street Corp boosted its position in Clorox by 3.1% during the third quarter. State Street Corp now owns 8,182,109 shares of the company's stock valued at $1,332,947,000 after purchasing an additional 245,525 shares in the last quarter. Mizuho Securities USA LLC raised its stake in Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock valued at $733,095,000 after buying an additional 4,490,421 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Clorox by 1.1% in the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company's stock worth $491,713,000 after purchasing an additional 33,970 shares during the last quarter. Stifel Financial Corp raised its stake in shares of Clorox by 1.7% in the third quarter. Stifel Financial Corp now owns 2,334,826 shares of the company's stock worth $380,370,000 after purchasing an additional 37,967 shares during the last quarter. Finally, Amundi raised its stake in shares of Clorox by 42.6% in the fourth quarter. Amundi now owns 1,032,283 shares of the company's stock worth $165,816,000 after purchasing an additional 308,234 shares during the last quarter. Institutional investors own 78.53% of the company's stock.

Remove Ads

Clorox Price Performance

CLX traded up $0.45 during trading on Wednesday, hitting $145.33. The company's stock had a trading volume of 1,105,411 shares, compared to its average volume of 1,471,174. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The business's fifty day simple moving average is $153.71 and its 200 day simple moving average is $160.08. The firm has a market capitalization of $17.90 billion, a price-to-earnings ratio of 39.71, a P/E/G ratio of 2.62 and a beta of 0.45.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period last year, the firm earned $2.16 EPS. On average, equities research analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.36%. The ex-dividend date is Wednesday, April 23rd. Clorox's dividend payout ratio is presently 133.33%.

Analyst Ratings Changes

Several research analysts have recently issued reports on CLX shares. StockNews.com cut Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Evercore ISI raised their price objective on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Wells Fargo & Company raised their target price on Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 4th. DA Davidson dropped their target price on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a report on Wednesday, February 5th. Finally, Royal Bank of Canada reaffirmed a "sector perform" rating and set a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $159.62.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.